Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Study Unveils Pupil Response Discrepancy in Depression Patients
In a recent study conducted by scientists from the Max Planck Institute of Psychiatry, researchers delved into the realm of pupillary reactions to uncover valuable insights into the physiological mechanisms underlying depression. The study, led by research group leader Victor…
FDA Approves ZEISS’ VISUMAX® 800 for Nearsightedness
The FDA has approved the VISUMAX® 800 equipped with SMILE® pro software from ZEISS. This state-of-the-art femtosecond laser technology is designed for the surgical treatment of nearsightedness, with or without astigmatism. The VISUMAX® 800 enters the U.S. market at a…
UCI Secures $575K Grant for Ophthalmology Research
The University of California, Irvine School of Medicine announced the reception of a prestigious Unrestricted Grant from the esteemed nonprofit organization, Research to Prevent Blindness (RPB). The substantial grant, amounting to $575,000 over a five-year period, will be dedicated to…
Leading the AI Ophthalmology Revolution – Johns Hopkins Medicine
Leading the AI Ophthalmology Revolution Johns Hopkins Medicine Source: Author: | Date: 2024-01-08 08:00:00 Source: Author: | Date: 2024-01-08 08:00:00
Exclusive Interview with Gilad Litvin, MD at CorNear Vision
We’re excited to invite you to an exclusive and enlightening interview that we recently conducted for OBN Spotlight TV. Join us as we sit down with Gilad Litvin, MD, – Founder and Chief Medical Officer at CorNeat Vision – to delve…
Ocuphire Pharma Gets FDA Nod for Dim Light Visual Acuity Trial
In a recent announcement, Ocuphire Pharma disclosed that it has secured approval from the U.S. Food and Drug Administration (FDA) under a special protocol assessment (SPA) for the clinical trial protocol and planned statistical analysis of its LYNX-2 phase 3…
FDA Unveils Updated Guidance for Ophthalmic Drugs
The FDA has released a significant update for the pharmaceutical industry, unveiling a revised draft guidance titled “Quality Considerations for Topical Ophthalmic Drug Products.” This comprehensive guidance addresses crucial quality considerations for various ophthalmic drug products, including gels, ointments, creams,…
Promising Treatment for Endothelial Disease
In a groundbreaking study published in The American Journal of Pathology, researchers at Mass Eye and Ear of the Harvard Medical School Department of Ophthalmology have unveiled a novel therapeutic approach using the neuropeptide α-melanocyte–stimulating hormone (α-MSH) to promote corneal…
Tips to Manage Eye Irritation After Cataract Surgery
Experiencing eye irritation after cataract surgery is not uncommon. While cataract surgery is generally safe and effective, it’s normal to experience some degree of discomfort in the postoperative phase. There can be several causes of eye irritation following the procedure.…
5 Things Ophthalmology Residents Should Know
Becoming an ophthalmology resident is a significant milestone for aspiring eye doctors. Ophthalmology is a complex field, and there are a few key things that new residents should be aware of before beginning their training. Here are the top 5…